N pts | % | |
---|---|---|
Gender | ||
Female | 11 | 44 |
Male | 14 | 56 |
Age | ||
<60 | 13 | 52 |
> r =60 | 12 | 48 |
ECOG | ||
0 | 9 | 36 |
1 | 15 | 60 |
2 | 1 | 4 |
Tobacco | ||
Current smoker | 4 | 16 |
Never smoker | 7 | 28 |
Former smoker | 14 | 56 |
Histology | ||
Adenocarcinoma | 22 | 88 |
Adenocarcinoma poorly differentiated | 2 | 8 |
Adeno-squamous | 1 | 4 |
T | ||
T1-2 | 12 | 48 |
T3-4 | 13 | 52 |
N | ||
N0 | 6 | 24 |
N+ | 19 | 76 |
M | ||
M0 | 7 | 28 |
M1 | 18 | 72 |
Lung metastases | ||
Presence | 7 | 28 |
Absence | 18 | 72 |
Liver metastases | ||
Presence | 2 | 8 |
Absence | 23 | 92 |
Bone metastases | ||
Presence | 10 | 40 |
Absence | 15 | 60 |
Brain metastases | ||
Presence | 8 | 32 |
Absence | 17 | 68 |
EGFR | ||
Wild type | 23 | 92 |
Mutant | 1 | 4 |
Unknown | 1 | 4 |
Line of treatment | ||
First/Induction (stage III) | 2 | 8 |
First | 21 | 84 |
Second | 1 | 4 |
Third | 1 | 4 |
Response | ||
Response | 18 | 72 |
Progression + Stabilization | 7 | 28 |
Maintenance | ||
No maintenance | 18 | 72 |
Maintenance | 7 | 28 |
Progression | ||
Not progressed | 6 | 24 |
Progressed | 19 | 76 |
Clinical status | ||
Alive | 12 | 48 |
Dead | 13 | 52 |